Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials

S Barbarot,A Wollenberg,J I Silverberg,M Deleuran,G Pellacani,J C Armario-Hita,Z Chen,B Shumel,L Eckert,A Gadkari,Y Lu,A B Rossi

JOURNAL OF DERMATOLOGICAL TREATMENT（2022）

引用 94|浏览43

暂无评分

关键词

Adults, atopic dermatitis, dupilumab, SCORAD

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要